Search

everythinglearnresearchcommunity

for

Search:↓

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Certain medications and maintaining adequate iron levels can help manage women's hair loss.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

Pregnancy reduces anxiety in rats, but finasteride reverses this effect.

AR gene not major factor in female hair loss; different from male hair loss.

Sex neurosteroids cause different effects on hippocampal synaptic plasticity in males and females.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.

Red clover extract improved hair, skin, mood, sleep, and tiredness in postmenopausal women.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

The estradiol valerate/dienogest oral contraceptive helps with heavy periods, may improve acne and symptoms in PCOS, and doesn't affect sexual function.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

Irregular menstrual cycles in teenagers are linked to a higher risk of polycystic ovary syndrome and metabolic syndrome.

Siblings with signs of virilization should be tested for non-classical congenital adrenal hyperplasia, which does not affect adult height but may impact fertility and well-being if untreated.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Minocycline may cause hair loss by increasing DHT levels, but finasteride can help counteract this effect.

Finasteride reduces hair growth in women with hirsutism and works better with electrolysis.

Possible link between androgens and COVID-19 severity; more research needed.

People with polycystic ovary syndrome (PCOS) are more likely to have higher levels of depression and anxiety, but their personality traits are similar to those without PCOS.

Chemical exposure may contribute to the rise in atopic diseases and needs more research.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

The effects of estrogen on human scalp hair growth are unclear and need more research.

Birth control pills increase certain receptor activities in female gerbil prostate glands and can lead to prostate changes.

The document concludes that hair loss is influenced by genetics and other factors, and while treatments like finasteride can help, they have limitations and side effects.